A review of breast cancer research in Malaysia

Medical Journal of Malaysia

Volumn 69, Issue , 2014, Pages 8-22

  Yip, Cheng Har ^a   Pathy, Nirmala Bhoo ^a   Teo, Soo Hwang ^b  

^a Department of Surgery ^*  (Malaysia)

^b CANCER RESEARCH INITIATIVES FOUNDATION   (Malaysia)

Author keywords

breast cancer; diagnosis; genetics; Malaysia; outcome; prognosis; review; screening; treatment

Indexed keywords

CA 15-3 ANTIGEN; CD45 ANTIGEN; CHECKPOINT KINASE 2; CYCLOPHOSPHAMIDE; CYTOKERATIN 5; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIRUBICIN; FLUOROURACIL; PHOSPHATIDYLINOSITOL 3, 4, 5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P53; STEM CELL FACTOR RECEPTOR; UNCLASSIFIED DRUG;

BONE SCINTISCANNING; BREAST CANCER; CANCER GRADING; CANCER RESEARCH; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CLINICAL PRACTICE; DECISION MAKING; ECHOGRAPHY; EVIDENCE BASED MEDICINE; GENETIC PREDISPOSITION; HISTOPATHOLOGY; HUMAN; LIFESTYLE; MALAYSIA; MAMMOGRAPHY; MOLECULARLY TARGETED THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PATIENT AUTONOMY; PHARMACOGENOMICS; PROTEIN EXPRESSION; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW;

EID: 84910614046     PISSN: 03005283     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (158)

1. Lim GCC RS, Halimah Y. (Eds.) Cancer Incidence in Peninsular Malaysia 2003-2005. National Cancer Registry. Kuala Lumpur 2008
2. Azizah Ab M DT, Bina Rai S, Norbayah Y, Nooraihan M, Noorshila S. Penang Cancer Regisstry 2004-2008.
3. http://globocan.iarc.fr Ga.
4. Pathy NB, Yip CH, Taib NA, Hartman M, Saxena N, Iau P, et al. Breast cancer in a multi-ethnic Asian setting: results from the SingaporeMalaysia hospital-based breast cancer registry. Breast. 2011 Apr; 20 Suppl 2: S75-80.
5. http://data.un.org/Data.aspx?d=PopDiv&f=variableID%3A41.
6. Yip CH, Taib NA, Mohamed I. Epidemiology of breast cancer in Malaysia. Asian Pac J Cancer Prev. 2006 Jul-Sep; 7(3): 369-74
7. Yip CH, Ng EH. Breast cancer--a comparative study between Malaysian and Singaporean women. Singapore Med J. 1996 Jun; 37(3): 264-7
8. Saxena N, Hartman M, Bhoo-Pathy N, Lim J., Aw TC, Iau P, et al. Breast cancer in South East Asia: comparison of presentation and outcome between a middle income and a high income country. World J Surg. 2012 Dec; 36(12): 2838-46.
9. Ng CH, Pathy NB, Taib NA, Teh YC, Mun KS, Amiruddin A, et al. Comparison of breast cancer in Indonesia and Malaysia--a clinicopathological study between Dharmais Cancer Centre Jakarta and University Malaya Medical Centre, Kuala Lumpur. Asian Pac J Cancer Prev. 2011; 12(11): 2943-6.
10. Hisham AN, Yip CH. Spectrum of breast cancer in Malaysian women: overview. World J Surg. 2003 Aug; 27(8): 921-3.
11. Taib NA, Akmal M, Mohamed I, Yip CH. Improvement in survival of breast cancer patients-trends over two time periods in a single institution in an Asia Pacific country, Malaysia. Asian Pac J Cancer Prev. 2011; 12(2): 345-9.
12. Ibrahim NI, Dahlui M, Aina EN, Al-Sadat N. Who are the breast cancer survivors in Malaysia? Asian Pac J Cancer Prev. 2012; 13(5): 2213-8.
13. Leong BD, Chuah JA, Kumar VM, Yip CH. Breast cancer in Sabah, Malaysia: a two year prospective study. Asian Pac J Cancer Prev. 2007 Oct-Dec; 8(4): 525-9.
14. Taib NA, Yip CH, Ibrahim M, Ng CJ, Farizah H. Breast cancer in malaysia: are our women getting the right message? 10 year-experience in a single institution in Malaysia. Asian Pac J Cancer Prev. 2007 JanMar; 8(1): 141-5.
15. Agarwal G, Pradeep PV, Aggarwal V, Yip CH, Cheung PS. Spectrum of breast cancer in Asian women. World J Surg. 2007 May; 31(5): 1031-40.
16. Bhoo-Pathy N, Hartman M, Yip CH, Saxena N, Taib NA, Lim SE, et al. Ethnic differences in survival after breast cancer in South East Asia. PLoS One. 2012; 7(2): e30995.
17. Hisham AN, Yip CH. Overview of breast cancer in Malaysian women: a problem with late diagnosis. Asian J Surg. 2004 Apr; 27(2): 130-3.
18. Matalqah L, Radaideh K, Yusoff ZM, Awaisu A. Predictors of breast cancer among women in a northern state of Malaysia: a matched casecontrol study. Asian Pac J Cancer Prev. 2011; 12(6): 1549-53.
19. Razif SM, Sulaiman S, Hanie SS, Aina EN, Rohaizak M, Fuad I, et al. The contribution of reproductive factors and family history towards premenopausal breast cancer risk in Kuala Lumpur, Malaysia. Med J Malaysia. 2011 Aug; 66(3): 220-6.
20. Norsa'adah B, Rusli BN, Imran AK, Naing I, Winn T. Risk factors ofbreast cancer in women in Kelantan, Malaysia. Singapore Med J. 2005 Dec; 46(12): 698-705.
21. Hejar AR, Chong FB, Rosnan H, Zailina H. Breast cancer and lifestyle risks among Chinese women in the Klang Valley in 2001. Med J Malaysia. 2004 Jun; 59(2): 226-32.
22. Kamarudin R, Shah SA, Hidayah N. Lifestyle factors and breast cancer: a case-control study in Kuala Lumpur, Malaysia. Asian Pac J Cancer Prev. 2006 Jan-Mar; 7(1): 51-4.
23. Rejali L, Jaafar MH, Ismail NH. Serum selenium level and other risk factors for breast cancer among patients in a Malaysian hospital. Environ Health Prev Med. 2007 May; 12(3): 105-10.
24. Shahar S, Salleh RM, Ghazali AR, Koon PB, Mohamud WN. Roles of adiposity, lifetime physical activity and serum adiponectin in occurrence of breast cancer among Malaysian women in Klang Valley. Asian Pac J Cancer Prev. 2010; 11(1): 61-6.
25. Sulaiman S, Shahril MR, Shaharudin SH, Emran NA, Muhammad R, Ismail F, et al. Fat intake and its relationship with preand postmenopausal breast cancer risk: a case-control study in Malaysia. Asian Pac J Cancer Prev. 2011; 12(9): 2167-78.
26. Suzana S, Cham BG, Ahmad Rohi G, Mohd Rizal R, Fairulnizal MN, Normah H, et al. Relationship between selenium and breast cancer: a case-control study in the Klang Valley. Singapore Med J. 2009 Mar; 50(3): 265-9.
27. Sharhar S, Normah H, Fatimah A, Fadilah RN, Rohi GA, Amin I, et al. Antioxidant intake and status, and oxidative stress in relation to breast cancer risk: a case-control study. Asian Pac J Cancer Prev. 2008 Apr-Jun; 9(2): 343-49.
28. Shahril MR, Sulaiman S, Shaharudin SH, Akmal SN. Healthy eating index and breast cancer risk among Malaysian women. Eur J Cancer Prev. 2013 Jul; 22(4): 342-7.
29. Ho CC, Rohaizak M, Zulkifli SZ, Siti-Aishah MA, Nor-Aini U, Sharifah-Akmal SH. Serum sex hormone levels in preand postmenopausal breast cancer patients. Singapore Med J. 2009 May; 50(5): 513-8.
30. Balraj P, Khoo AS, Volpi L, Tan JA, Nair S, Abdullah H. Mutation analysis of the BRCA1 gene in Malaysian breast cancer patients. Singapore Med J. 2002 Apr; 43(4): 194-7.
31. Toh GT, Kang P, Lee SS, Lee DS, Lee SY, Selamat S, et al. BRCA1 and BRCA2 germline mutations in Malaysian women with early-onset breast cancer without a family history. PLoS One. 2008; 3(4): e2024.
32. Kang P, Mariapun S, Phuah SY, Lim LS, Liu J, Yoon SY, et al. Large BRCA1 and BRCA2 genomic rearrangements in Malaysian high risk breastovarian cancer families. Breast Cancer Res Treat. 2010 Nov; 124(2): 579-84.
33. Sharifah NA, Nurismah MI, Lee HC, Aisyah AN, Clarence-Ko CH, Naqiyah I, et al. Identification of novel large genomic rearrangements at the BRCA1 locus in Malaysian women with breast cancer. Cancer Epidemiol. 2010 Aug; 34(4): 442-7.
34. Thirthagiri E, Lee SY, Kang P, Lee DS, Toh GT, Selamat S, et al. Evaluation of BRCA1 and BRCA2 mutations and risk-prediction models in a typical Asian country (Malaysia) with a relatively low incidence of breast cancer. Breast Cancer Res. 2008; 10(4): R59.
35. Yip CH, Taib NA, Choo WY, Rampal S, Thong MK, Teo SH. Clinical and pathologic differences between BRCA1-, BRCA2-, and non-BRCAassociated breast cancers in a multiracial developing country. World J Surg. 2009 Oct; 33(10): 2077-81.
36. Phuah SY, Looi LM, Hassan N, Rhodes A, Dean S, Taib NA, et al. Triplenegative breast cancer and PTEN (phosphatase and tensin homologue)loss are predictors of BRCA1 germline mutations in women with early-onset and familial breast cancer, but not in women with isolated late-onset breast cancer. Breast Cancer Res. 2012 Nov 2; 14(6): R142.
37. Yoon SY, Thong MK, Taib NA, Yip CH, Teo SH. Genetic counseling for patients and families with hereditary breast and ovarian cancer in a developing Asian country: an observational descriptive study. Fam Cancer. 2011 Jun; 10(2): 199-205.
38. Taib N, Woo Y, Yoon S, Kartini R, Thong M, Yip C, et al. Early experience in a breast and ovarian cancer risk management clinic in Malaysia. Hered Cancer Clin Pract. 2012; 10(Suppl 2): A58.
39. Lee DS, Yoon SY, Looi LM, Kang P, Kang IN, Sivanandan K, et al. Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients. Breast Cancer Res. 2012; 14(2): R66.
40. Phuah SY, Lee SY, Kang P, Kang IN, Yoon SY, Thong MK, et al. Prevalence of PALB2 mutations in breast cancer patients in multi-ethnic Asian population in Malaysia and Singapore. PLoS One. 2013; 8(8): e73638.
41. Thirthagiri E, Cheong LS, Yip CH, Teo SH. CHEK2*1100delC does not contribute to risk to breast cancer among Malay, Chinese and Indians in Malaysia. Fam Cancer. 2009; 8(4): 355-8.
42. Leong PP, Muhammad R, Ibrahim N, Cheong SK, Seow HF. HLA-A and breast cancer in West Peninsular Malaysia. Med Oncol. 2011 Mar; 28(1): 51-6.
43. Zheng W, Zhang B, Cai Q, Sung H, Michailidou K, Shi J, et al. Common genetic determinants of breast-cancer risk in East Asian women: a collaborative study of 23 637 breast cancer cases and 25 579 controls. Human molecular genetics. 2013 Jun 15; 22(12): 2539-50.
44. Al-Dubai SA, Qureshi AM, Saif-Ali R, Ganasegeran K, Alwan MR, Hadi JI. Awareness and knowledge of breast cancer and mammography among a group of Malaysian women in Shah Alam. Asian Pac J Cancer Prev. 2011; 12(10): 2531-8.
45. Kanaga KC, Nithiya J, Shatirah MF. Awareness of breast cancer and screening procedures among Malaysian women. Asian Pac J Cancer Prev. 2011; 12(8): 1965-7.
46. Abdul Hadi M, Hassali MA, Shafie AA, Awaisu A. Knowledge and perception of breast cancer among women of various ethnic groups in the state of Penang: a cross-sectional survey. Med Princ Pract. 2010; 19(1): 61-7.
47. Dunn RA, Tan AK. Utilization of breast cancer screening methods in a developing nation: results from a nationally representative sample of Malaysian households. Breast J. 2011 Jul-Aug; 17(4): 399-402.
48. Al-Dubai SA, Ganasegeran K, Alabsi AM, Abdul Manaf MR, Ijaz S, Kassim S. Exploration of barriers to breast-self examination among urban women in Shah Alam, Malaysia: a cross sectional study. Asian Pac J Cancer Prev. 2012; 13(4): 1627-32.
49. Akhtari-Zavare M, Juni MH, Said SM, Ismail IZ. Beliefs and behavior of Malaysia undergraduate female students in a public university toward breast self-examination practice. Asian Pac J Cancer Prev. 2013; 14(1): 57-61.
50. Al-Naggar RA, Bobryshev YV, Al-Jashamy K. Practice of breast selfexamination among women in Malaysia. Asian Pac J Cancer Prev. 2012; 13(8): 3829-33.
51. Al-Naggar RA, Al-Naggar DH, Bobryshev YV, Chen R, Assabri A. Practiceand barriers toward breast self-examination among young Malaysian women. Asian Pac J Cancer Prev. 2011; 12(5): 1173-8.
52. Rosmawati NH. Knowledge, attitudes and practice of breast selfexamination among women in a suburban area in Terengganu, Malaysia. Asian Pac J Cancer Prev. 2010; 11(6): 1503-8.
53. Dahlui M, Gan DE, Taib NA, Lim J.. Breast screening and health issues among rural females in Malaysia: how much do they know and practice? Prev Med. 2013; 57 Suppl: S18-20.
54. Dahlui M, Ng C, Al-Sadat N, Ismail S, Bulgiba A. Is breast self examination (BSE) still relevant? A study on BSE performance among female staff of University of Malaya. Asian Pac J Cancer Prev. 2011; 12(2): 369-72.
55. Dunn RA, Tan A, Samad I. Does performance of breast self-exams increase the probability of using mammography: evidence from Malaysia. Asian Pac J Cancer Prev. 2010; 11(2): 417-21.
56. Dahlui M, Gan DE, Taib NA, Pritam R, Lim J. Predictors of breast cancer screening uptake: a pre intervention community survey in Malaysia. Asian Pac J Cancer Prev. 2012; 13(7): 3443-9.
57. Al-Naggar RA, Bobryshev YV. Practice and barriers of mammography among Malaysian women in the general population. Asian Pac J Cancer Prev. 2012; 13(8): 3595-600.
58. Rosmawati NH. The usage and knowledge of mammography among women in sub-urban area in Terengganu, Malaysia. Asian Pac J Cancer Prev. 2010; 11(3): 767-71.
59. Parsa P, Kandiah M. Predictors of adherence to clinical breast examination and mammography screening among Malaysian women. Asian Pac J Cancer Prev. 2010; 11(3): 681-8.
60. Chan PY, Latip LS. A case control study in factors that affect mammogram compliance. Med J Malaysia. 2011 Dec; 66(5): 456-61.
61. Abdullah NN, Aziz NA, Rampal S, Al-Sadat N. Mammography screening uptake among hospital personnel in Kuala Lumpur tertiary hospital. Asian Pac J Cancer Prev. 2011; 12(10): 2643-7.
62. Subramanian P, Oranye NO, Masri AM, Taib NA, Ahmad N. Breast cancer knowledge and screening behaviour among women with a positive family history: a cross sectional study. Asian Pac J Cancer Prev. 2013; 14(11): 6783-90.
63. Yip CH, bt Mohd Taib NA, Lau PC. Does a positive family history influence the presentation of breast cancer? Asian Pac J Cancer Prev. 2008 Jan-Mar; 9(1): 63-5.
64. Taib NA, Yip CH, Low WY. Recognising symptoms of breast cancer as a reason for delayed presentation in Asian women--the psycho-sociocultural model for breast symptom appraisal: opportunities for intervention. Asian Pac J Cancer Prev. 2011; 12(6): 1601-8.
65. Devi BC, Tang TS, Corbex M. Reducing by half the percentage of latestage presentation for breast and cervix cancer over 4 years: a pilot study of clinical downstaging in Sarawak, Malaysia. Ann Oncol. 2007 Jul; 18(7): 1172-6.
66. Ho EL, Ng KH, Wong JH, Wang HB. Quality assurance in mammography: College of Radiology Survey in Malaysia. Med J Malaysia. 2006 Jun; 61(2): 204-8.
67. Ranganathan S, Faridah Y, Ng KH. Moving into the digital era: a novel experience with the first full-field digital mammography system in Malaysia. Singapore Med J. 2007 Sep; 48(9): 804-7.
68. Thevi Rajendran P, Krishnapillai V, Tamanang S, Kumari Chelliah K. Comparison of Image Quality Criteria between Digital Storage Phosphor Plate in Mammography and Full-Field Digital Mammography in the Detection of Breast Cancer. Malays J Med Sci. 2012 Jan; 19(1): 52-9.
69. Zulfiqar M, Rohazly I, Rahmah M. Do the majority of Malaysian women have dense breasts on mammogram? Biomed Imaging Interv J. 2011 Apr; 7(2): e14.
70. Voon NS, Chelliah KK. Is there an influence of dietary habits on breast density as seen on digital mammograms? Asian Pac J Cancer Prev. 2011; 12(8): 1969-72.
71. Jamal N, Ng KH, Looi LM, McLean D, Zulfiqar A, Tan SP, et al. Quantitative assessment of breast density from digitized mammograms into Tabar's patterns. Phys Med Biol. 2006 Nov 21; 51(22): 5843-57.
72. Alhabshi SM, Rahmat K, Abdul Halim N, Aziz S, Radhika S, Gan GC, et al. Semi-quantitative and qualitative assessment of breast ultrasound elastography in differentiating between malignant and benign lesions. Ultrasound Med Biol. 2013 Apr; 39(4): 568-78.
73. Hasni H, Meah FA, Norlia A, Sharifah NA, Zulfiqar A. Ultrasound in the assessment of the palpable breast mass. Med J Malaysia. 2004 Oct; 59(4): 486-94.
74. Suppiah S, Rahmat K, Mohd-Shah MN, Azlan CA, Tan LK, Aziz YF, et al. Improved diagnostic accuracy in differentiating malignant and benign lesions using single-voxel proton MRS of the breast at 3 T MRI. Clin Radiol. 2013 Sep; 68(9): e502-10.
75. Tan SL, Rahmat K, Rozalli FI, Mohd-Shah MN, Aziz YF, Yip CH, et al. Differentiation between benign and malignant breast lesions using quantitative diffusion-weighted sequence on 3 T MRI. Clin Radiol. 2014 Jan; 69(1): 63-71.
76. Yip CH, Paramsothy M. Value of routine 99mTc-MDP bone scintigraphy in the detection of occult skeletal metastases in women with primary breast cancer. Breast. 1999 Oct; 8(5): 267-9.
77. Tham TM, Iyengar KR, Taib NA, Yip CH. Fine needle aspiration biopsy, core needle biopsy or excision biopsy to diagnose breast cancer – which is the ideal method? Asian Pac J Cancer Prev. 2009 Jan-Mar; 10(1): 1558.
78. Hisham AN, Harjit K, Fatimah O, Yun SI. Prebiopsy localisation of impalpable breast lesions. Med J Malaysia. 2004 Aug; 59(3): 402-5.
79. Ng CH, Lee KT, Taib NA, Yip CH. Experience with hookwire localization excision biopsy at a medical centre in Malaysia. Singapore Med J. 2010 Apr; 51(4): 306-10.
80. Yip CH, Jayaram G, Alhady SF. The experience with fine needle aspiration cytology in the management of palpable breast lumps in the University Hospital Kuala Lumpur. Med J Malaysia. 2000 Sep; 55(3): 363-7.
81. Jayaram G, Alhady SF, Yip CH. Cytological analysis of breast lesions: a review of 780 cases. Malays J Pathol. 1996 Dec; 18(2): 81-7.
82. Jayaram G, Elsayed EM. Cytologic evaluation of prognostic markers in breast carcinoma. Acta Cytol. 2005 Nov-Dec; 49(6): 605-10.
83. Jayaram G, Swain M, Chew MT, Yip CH. Cytologic appearances in invasive lobular carcinoma of the breast. A study of 21 cases. Acta Cytol. 2000 Mar-Apr; 44(2): 169-74.
84. Jayaram G, Swain M, Chew MT, Yip CH, Moosa F. Cytology of mucinous carcinoma of breast: a report of 28 cases with histological correlation. Malays J Pathol. 2000 Dec; 22(2): 65-71.
85. Yeap BH, Muniandy S, Lee SK, Sabaratnam S, Singh M. Specimen shrinkage and its influence on margin assessment in breast cancer. Asian J Surg. 2007 Jul; 30(3): 183-7.
86. Sheikh MK, Khan FA, Imran Abdul Khalid IK, Kumar G. Age specific histologic types of carcinoma breast in Malaysians. J Coll Physicians Surg Pak. 2009 Mar; 19(3): 201-2.
87. Yip CH, Pathy NB, Uiterwaal CS, Taib NA, Tan GH, Mun KS, et al. Factors affecting estrogen receptor status in a multiracial Asian country: an analysis of 3557 cases. Breast. 2011 Apr; 20 Suppl 2: S60-4.
88. Tan GH, Choo WY, Taib NA, Yip CH. Factors associated with HER2 overexpression in breast cancer: Experience in an Asian developing country. Asian Pac J Cancer Prev. 2009; 10(5): 837-40.
89. Tan GH, Taib NA, Choo WY, Teo SH, Yip CH. Clinical characteristics of triple-negative breast cancer: experience in an Asian developing country. Asian Pac J Cancer Prev. 2009 Jul-Sep; 10(3): 395-8.
90. Teoh KH, Looi LM, Sabaratnam S, Cheah PL, Nazarina AR, Mun KS. An analysis of predictive biomarkers in routine histopathological reporting of infiltrating ductal breast carcinoma in a tertiary hospital in Malaysia with a focus on limitations and directions for future development. Malays J Pathol. 2011 Jun; 33(1): 35-42.
91. Ch'ng ES, Tuan Sharif SE, Jaafar H. Characteristics of invasive breast ductal carcinoma, NOS, diagnosed in a tertiary institution in the East Coast of Malaysia with a focus on tumor angiogenesis. Asian Pac J Cancer Prev. 2012; 13(9): 4445-52.
92. Kanapathy Pillai SK, Tay A, Nair S, Leong CO. Triple-negative breast cancer is associated with EGFR, CK5/6 and c-KIT expression in Malaysian women. BMC Clin Pathol. 2012; 12: 18.
93. Devi CR, Tang TS, Corbex M. Incidence and risk factors for breast cancer subtypes in three distinct South-East Asian ethnic groups: Chinese, Malay and natives of Sarawak, Malaysia. Int J Cancer. 2012 Dec 15; 131(12): 2869-77.
94. Ng CH, Pathy NB, Taib NA, Mun KS, Rhodes A, Yip CH. The estrogen receptor negative-progesterone receptor positive breast carcinoma is a biological entity and not a technical artifact. Asian Pac J Cancer Prev. 2012; 13(4): 1111-3.
95. Aziz SA, Pervez S, Khan S, Kayani N, Rahbar MH. Relationship of p53 expression with clinicopathological variables and disease outcome: a prospective study on 315 consecutive breast carcinoma patients. Malays J Pathol. 2001 Dec; 23(2): 65-71.
96. Dean SJ, Perks CM, Holly JM, Bhoo-Pathy N, Looi LM, Mohammed NA, et al. Loss of PTEN Expression Is Associated With IGFBP2 Expression, Younger Age, and Late Stage in Triple-Negative Breast Cancer. Am J Clin Pathol. 2014 Mar; 141(3): 323-33.
97. Velaiutham S, Taib NA, Ng KL, Yoong BK, Yip CH. Does the pre-operative value of serum CA15-3 correlate with survival in breast cancer? Asian Pac J Cancer Prev. 2008 Jul-Sep; 9(3): 445-8.
98. Rohaizak M, Khan FJ, Jasmin JS, Mohd Latar NH, Abdullah SS. Ultracision versus electrocautery in performing modified radical mastectomy and axillary lymph node dissection for breast cancer: a prospective randomized control trial. Med J Malaysia. 2013 Jun; 68(3): 204-7.
99. Rica MA, Norlia A, Rohaizak M, Naqiyah I. Preemptive ropivacaine local anaesthetic infiltration versus postoperative ropivacaine wound infiltration in mastectomy: postoperative pain and drain outputs. Asian J Surg. 2007 Jan; 30(1): 34-9.
100. Haron NH, Taib NA, Yip CH. Is clinical assessment of the axilla a reliable indicator for lymph node metastases in breast cancer? ANZ J Surg. 2008 Nov; 78(11): 943-4.
101. Yip CH, Taib NA, Tan GH, Ng KL, Yoong BK, Choo WY. Predictors of axillary lymph node metastases in breast cancer: is there a role for minimal axillary surgery? World J Surg. 2009 Jan; 33(1): 54-7
102. Pathy NB, Verkooijen HM, Taib NA, Hartman M, Yip CH. Impact of breast surgery on survival in women presenting with metastatic breast cancer. Br J Surg. 2011 Nov; 98(11): 1566-72.
103. Shameem H, Yip CH, Fong E. Immediate breast reconstruction after mastectomy--why do women choose this option? Asian Pac J Cancer Prev. 2008 Jul-Sep; 9(3): 409-12.
104. Wijayahadi N, Haron MR, Stanslas J, Yusuf Z. Changes in cellular immunity during chemotherapy for primary breast cancer with anthracycline regimens. J Chemother. 2007 Dec; 19(6): 716-23
105. Hassan BA, Yusoff ZB, Hassali MA, Othman SB, Weiderpass E. Impact of chemotherapy on hypercalcemia in breast and lung cancer patients. Asian Pac J Cancer Prev. 2012; 13(9): 4373-8.
106. Phua CE, Bustam AZ, Yusof MM, Saad M, Yip CH, Taib NA, et al. Risk of treatment related death and febrile neutropaenia with taxane-based adjuvant chemotherapy for breast cancer in a middle income country outside a clinical trial setting. Asian Pac J Cancer Prev. 2012; 13(9): 4623-6
107. Tiong V, Rozita AM, Taib NA, Yip CH, Ng CH. Incidence of Chemotherapy-Induced Ovarian Failure in Premenopausal Women Undergoing Chemotherapy for Breast Cancer. World J Surg. 2014 Apr 4
108. Azrif M, Ibrahim J, Aslan NM, Fong KV, Ismail F. Neoadjuvant chemotherapy for locally advanced breast cancer in a malaysian tertiary hospital. Asian Pac J Cancer Prev. 2011; 12(1): 157-62.
109. Chong HY, Taib NA, Rampal S, Saad M, Bustam AZ, Yip CH. Treatment options for locally advanced breast cancer--experience in an Asian tertiary hospital. Asian Pac J Cancer Prev. 2010; 11(4): 913-7.
110. Hassan BA, Yusoff ZB. Genetic polymorphisms in the three Malaysian races effect granisetron clinical antiemetic actions in breast cancer patients receiving chemotherapy. Asian Pac J Cancer Prev. 2011; 12(1): 185-91.
111. Teh LK, Mohamed NI, Salleh MZ, Rohaizak M, Shahrun NS, Saladina JJ, et al. The risk of recurrence in breast cancer patients treated with tamoxifen: polymorphisms of CYP2D6 and ABCB1. AAPS J. 2012 Mar; 14(1): 52-9.
112. Shaharudin SH, Sulaiman S, Emran NA, Shahril MR, Hussain SN. The use of complementary and alternative medicine among Malay breast cancer survivors. Altern Ther Health Med. 2011 Jan-Feb; 17(1): 50-6
113. Leong BD, Chuah JA, Kumar VM, Rohamini S, Siti ZS, Yip CH. Trends of breast cancer treatment in Sabah, Malaysia: a problem with lack of awareness. Singapore Med J. 2009 Aug; 50(8): 772-6.
114. Biswal BM, Sulaiman SA, Ismail HC, Zakaria H, Musa KI. Effect of Withania somnifera (Ashwagandha) on the development of chemotherapy-induced fatigue and quality of life in breast cancer patients. Integr Cancer Ther. 2013 Jul; 12(4): 312-22.
115. Nesaretnam K, Selvaduray KR, Abdul Razak G, Veerasenan SD, Gomez PA. Effectiveness of tocotrienol-rich fraction combined with tamoxifen in the management of women with early breast cancer: a pilot clinical trial. Breast Cancer Res. 2010; 12(5): R81.
116. Abdullah NA, Wan Mahiyuddin WR, Muhammad NA, Ali ZM, Ibrahim L, Ibrahim Tamim NS, et al. Survival rate of breast cancer patients in Malaysia: a population-based study. Asian Pac J Cancer Prev. 2013; 14(8): 4591-4.
117. Mohd Taib NA, Yip CH, Mohamed I. Survival analysis of Malaysian women with breast cancer: results from the University of Malaya Medical Centre. Asian Pac J Cancer Prev. 2008 Apr-Jun; 9(2): 197-202
118. Ong TA, Yip CH. Short-term survival in breast cancer: the experience of the University of Malaya Medical Centre. Asian J Surg. 2003 Jul; 26(3): 169-75.
119. Saxena N, Hartman M, Yip CH, Bhoo-Pathy N, Khin LW, Taib NA, et al. Does the axillary lymph node ratio have any added prognostic value over pN staging for South East Asian breast cancer patients? PLoS One. 2012; 7(9): e45809.
120. Choong LP, Taib NA, Rampal S, Saad M, Bustam AZ, Yip CH. High tumour stage and margin clearance are still important prognostic factors for post-mastectomy locoregional recurrence in Malaysia. Asian Pac J Cancer Prev. 2010; 11(5): 1409-16.
121. Bhoo Pathy N, Uiterwaal CS, Taib NA, Verkooijen HM, Yip CH. Gradually implemented new biomarkers for prognostication of breast cancer: complete case analysis may introduce bias. J Clin Epidemiol. 2012 May; 65(5): 568-71.
122. Al-Naggar RA, Isa ZM, Shah SA, Nor MI, Chen R, Ismail F, et al. Eight year survival among breast cancer Malaysian women from University Kebangsaan Malaysia Medical Centre. Asian Pac J Cancer Prev. 2009; 10(6): 1075-8.
123. Mujar M, Dahlui M, Yip CH, Taib NA. Delays in time to primary treatment after a diagnosis of breast cancer: does it impact survival? Prev Med. 2013 Mar; 56(3-4): 222-4.
124. Lim GC, Aina EN, Cheah SK, Ismail F, Ho GF, Tho LM, et al. Closing the global cancer divideperformance of breast cancer care services in a middle income developing country. BMC Cancer. 2014; 14: 212
125. Nor Aina E. National Cancer Patient Registry--Breast Cancer (NCPRBreast Cancer). Med J Malaysia. 2008 Sep; 63 Suppl C: 72-3
126. Bhoo-Pathy N, Yip CH, Hartman M, Saxena N, Taib NA, Ho GF, et al. Adjuvant! Online is overoptimistic in predicting survival of Asian breast cancer patients. Eur J Cancer. 2012 May; 48(7): 982-9.
127. Phua CE, Bustam AZ, Yip CH, Taib NA. Prognostic factors for elderly breast cancer patients in University Malaya Medical Centre, Malaysia. Asian Pac J Cancer Prev. 2010; 11(5): 1205-11.
128. Yip CH, Taib NA, Abdullah MM, Wahid I. Breast cancer in pregnancyour experience with six patients in the University Hospital, Kuala Lumpur. Med J Malaysia. 2000 Sep; 55(3): 308-10.
129. Sharifah NA, Lee BR, Clarence-Ko CH, Tan GC, Shiran MS, Naqiyah I, et al. C-erbB-2 onco-protein expression in breast cancer: relationship to tumour characteristics and short-term survival in Universiti Kebansaan Malaysia Medical Centre. Asian Pac J Cancer Prev. 2008 Oct-Dec; 9(4): 663-70.
130. Nik Jaafar NR, Selamat Din SH, Mohamed Saini S, Ahmad SN, Midin M, Sidi H, et al. Clinical depression while caring for loved ones with breast cancer. Compr Psychiatry. 2014 Jan; 55 Suppl 1: S52-9
131. Loh SY, Packer T, Chinna K, Quek KF. Effectiveness of a patient selfmanagement programme for breast cancer as a chronic illness: a non-randomised controlled clinical trial. J Cancer Surviv. 2013 Sep; 7(3): 331-42.
132. Loh SY, Ong L, Ng LL, Chew SL, Lee SY, Boniface G. Qualitative experiences of breast cancer survivors on a self-management intervention: 2-year post-intervention. Asian Pac J Cancer Prev. 2011; 12(6): 1489-95.
133. Ram S, Narayanasamy R, Barua A. Effectiveness of Group Psychoeducation on Well-being and Depression Among Breast Cancer Survivors of Melaka, Malaysia. Indian J Palliat Care. 2013 Jan; 19(1): 34-9.
134. Muhamad M, Afshari M, Kazilan F. Family support in cancer survivorship. Asian Pac J Cancer Prev. 2011; 12(6): 1389-97.
135. Abu Kassim NL, Mohd Hanafiah K, Samad-Cheung H, Rahman MT. Influence of Support Group Intervention on Quality of Life of Malaysian Breast Cancer Survivors. Asia Pac J Public Health. 2013 Feb
136. Yusuf A, Ahmad Z, Keng SL. Quality of life in Malay and Chinese women newly diagnosed with breast cancer in Kelantan, Malaysia. Asian Pac J Cancer Prev. 2013; 14(1): 435-40.
137. Yusuf A, Ab Hadi IS, Mahamood Z, Ahmad Z, Keng SL. Understanding the breast cancer experience: a qualitative study of Malaysian women. Asian Pac J Cancer Prev. 2013; 14(6): 3689-98.
138. Yusoff N, Low WY, Yip CH. Reliability and validity of the Brief COPE Scale (English version) among women with breast cancer undergoing treatment of adjuvant chemotherapy: a Malaysian study. Med J Malaysia. 2010 Mar; 65(1): 41-4.
139. Yusoff N, Low WY, Yip CH. Psychometric properties of the Malay version of the Breast Module (BR23). Singapore Med J. 2012 Jan; 53(1): 36-9.
140. Zainal NZ, Shuib N, Bustam AZ, Sabki ZA, Guan NC. Reliability and validity of the Malay Version of the BreastImpact of Treatment Scale (MVBITS) in breast cancer women undergoing chemotherapy. Asian Pac J Cancer Prev. 2013; 14(1): 463-8.
141. Yusoff N, Low WY, Yip CH. Psychometric properties of the Malay Version of the hospital anxiety and depression scale: a study of husbands of breast cancer patients in Kuala Lumpur, Malaysia. Asian Pac J Cancer Prev. 2011; 12(4): 915-7.
142. Hassan BA, Yusoff ZB. Negative impact of chemotherapy on breast cancer patients QOL-utility of antiemetic treatment guidelines and the role of race. Asian Pac J Cancer Prev. 2010; 11(6): 1523-7.
143. Shaharudin SH, Sulaiman S, Shahril MR, Emran NA, Akmal SN. Dietary changes among breast cancer patients in Malaysia. Cancer Nurs. 2013 Mar-Apr; 36(2): 131-8.
144. Yaw YH, Kandiah M, Shariff ZM, Mun CY, Hashim Z, Yusof RM, et al. Pattern of weight changes in women with breast cancer. Asian Pac J Cancer Prev. 2010; 11(6): 1535-40.
145. Yaw YH, Shariff ZM, Kandiah M, Mun CY, Yusof RM, Othman Z, et al. Weight changes and lifestyle behaviors in women after breast cancer diagnosis: a cross-sectional study. BMC Public Health. 2011; 11: 309
146. Loh SY, Chew SL, Lee SY. Barriers to exercise: perspectives from multiethnic cancer survivors in Malaysia. Asian Pac J Cancer Prev. 2011; 12(6): 1483-8.
147. Saibul N, Shariff ZM, Rahmat A, Sulaiman S, Yaw YH. Use of complementary and alternative medicine among breast cancer survivors. Asian Pac J Cancer Prev. 2012; 13(8): 4081-6.
148. Muhamad M, Merriam S, Suhami N. Why breast cancer patients seek traditional healers. Int J Breast Cancer. 2012; 2012: 689168.
149. Norsa'adah B, Rahmah M., Rampal KG, Knight A. Understanding barriers to Malaysian women with breast cancer seeking help. Asian Pac J Cancer Prev. 2012; 13(8): 3723-30.
150. Norsa'adah B, Rampal KG, Rahmah M., Naing NN, Biswal BM. Diagnosis delay of breast cancer and its associated factors in Malaysian women. BMC Cancer. 2011; 11: 141.
151. Ghazali SM, Othman Z, Cheong KC, Hock LK, Wan Mahiyuddin WR, Kamaluddin MA, et al. Non-practice of breast self examination and marital status are associated with delayed presentation with breast cancer. Asian Pac J Cancer Prev. 2013; 14(2): 1141-5.
152. Yusoff N, Taib NA, Ahmad A. The health seeking trajectories of Malaysian women and their husbands in delay cases of breast cancer: a qualitative study. Asian Pac J Cancer Prev. 2011; 12(10): 2563-70
153. Taib NA, Yip CH, Low WY. A Grounded Explanation of Why Women Present with Advanced Breast Cancer. World J Surg. 2013 Nov 27.
154. Abdullah A, Abdullah KL, Yip CH, Teo SH, Taib NA, Ng CJ. The decisionmaking journey of malaysian women with early breast cancer: a qualitative study. Asian Pac J Cancer Prev. 2013; 14(12): 7143-7.
155. Gopal RL, Beaver K, Barnett T, Ismail NS. A comparison of the information needs of women newly diagnosed with breast cancer in Malaysia and the United kingdom. Cancer Nurs. 2005 Mar-Apr; 28(2): 132-40.
156. Lei CP, Har YC, Abdullah KL. Informational needs of breast cancer patients on chemotherapy: differences between patients' and nurses' perceptions. Asian Pac J Cancer Prev. 2011; 12(3): 797-802
157. Tan FL, Loh SY, Su TT, Veloo VW, Ng LL. Return to work in multi-ethnic breast cancer survivors--a qualitative inquiry. Asian Pac J Cancer Prev. 2012; 13(11): 5791-7.
158. Bhoo-Pathy N, Yip CH, Hartman M, Uiterwaal CS, Devi BC, Peeters PH, et al. Breast cancer research in Asia: adopt or adapt Western knowledge? Eur J Cancer. 2013 Feb; 49(3): 703-9.